The science is ready. The factories are being built. But between a finished precision fermentation product and a European consumer’s plate lies a regulatory labyrinth that has tested the patience of even the most well-funded startups. Average Novel Food approval times have stretched to 30 months — nearly double the 18-month statutory timeline — and some applications have languished for five years.

Now, the industry is taking matters into its own hands.

Food Fermentation Europe, a coalition of precision fermentation companies and over 60 scientists, has emerged as the sector’s most important non-governmental force. Formally constituted in late 2025, the alliance represents a strategic shift: rather than waiting for Brussels to fix the approval process, the industry is actively building the regulatory infrastructure alongside it.

The coalition’s first major achievement was deceptively simple but profoundly important. Working with the Precision Fermentation Alliance, Food Fermentation Europe produced a refined, harmonised definition of precision fermentation — ending years of divergent interpretations that had caused confusion among regulators, investors, and policymakers alike.

Why does a definition matter? Because every Novel Food application must classify the production process. When different companies described functionally identical processes in fundamentally different ways, EFSA assessors struggled to apply consistent evaluation criteria. The harmonised definition creates a common language that should accelerate every application that follows.

The EU Biotech Act, which entered into force in recent months, was supposed to be the sector’s regulatory breakthrough. In many ways, it delivered. The Act expanded EFSA’s pre-submission guidance, creating more technical touchpoints between precision fermentation companies and the agency before formal applications are filed. For companies navigating the complex Novel Food dossier requirements, this early engagement can save months of back-and-forth.

But the Act also contained a critical exclusion that sent shockwaves through the industry: novel foods were left out of the regulatory sandbox provisions. These sandboxes — controlled environments where innovative products can be tested under relaxed regulatory conditions — were designed precisely for emerging technologies. GFI Europe called the exclusion a missed opportunity, arguing that precision fermentation products are exactly the kind of innovation that sandboxes were created to support.

The result is a paradox. The EU is investing 350 million euros in fermentation infrastructure while simultaneously maintaining one of the world’s slowest approval processes for the products those facilities are designed to produce. It is building the factories but not yet clearing the path to market.

A second Biotech Act, expected in late 2026, is widely seen as the opportunity to correct this imbalance. The precision fermentation industry is already mobilising to ensure novel foods are included in the next legislative round.

The EU Advanced Fermentation Conference, held in Brussels on February 9, 2026, marked a turning point in the relationship between industry, regulators, and policymakers. For the first time, the European Commission convened precision fermentation stakeholders alongside regulatory officials in a structured dialogue format.

The conference validated several key developments from the EU’s Strategy for European Life Sciences. A Regulators and Innovators Forum, launching between 2026 and 2028, will create permanent channels between precision fermentation companies and EU regulatory bodies. A Bioeconomy Investment Deployment Group will coordinate capital allocation across the fermentation value chain, using blended-finance mechanisms to de-risk first-of-a-kind production facilities.

Perhaps most significantly, the Commission announced plans for a single online entry point for bio-based product classification — eliminating the duplicative submission processes that have been a persistent source of frustration for companies operating across multiple regulatory frameworks.

The regulatory question is not academic. It is a competitive one. While Europe deliberates, other markets are moving.

Remilk launched its recombinant dairy protein product “New Milk” in Israel and is targeting US market entry in 2026, pivoting from its planned Danish facility to contract manufacturing in Spain and North America. Perfect Day’s Gujarat production facility is on track for a second-half 2026 start, with full ramp-up expected in 2027. These companies are not waiting for a single market to resolve its regulatory questions — they are building global supply chains that route around bottlenecks.

Europe’s precision fermentation market is projected to grow from USD 2.16 billion in 2025 to USD 3.09 billion in 2026. European private sector investment reached 470 million euros in 2024, representing 23 percent year-on-year growth. According to GFI Europe, sustained government investment in alternative proteins could contribute 111 billion euros annually to the EU economy.

The numbers make the strategic calculation clear: Europe has the science, the capital, and the consumer demand. What it needs is regulatory velocity.

The next 18 months will determine whether Europe’s coalition-driven approach can deliver results faster than traditional legislative timelines would suggest.

The immediate priorities are concrete. The Regulators and Innovators Forum must become operational by mid-2026, creating the permanent dialogue channels the industry needs. The Bioeconomy Investment Deployment Group must begin allocating the 200 million euros earmarked for 2026-2027 fermentation funding. And the second Biotech Act must include novel foods in sandbox provisions — the single most impactful regulatory change the Commission could make.

The Food Fermentation Europe coalition is positioning itself as the interlocutor for all of these processes, coordinating industry input, providing scientific evidence, and maintaining pressure on timelines. With 60-plus scientists and growing membership, it has the technical credibility that policymakers require.

The precision fermentation industry learned a hard lesson over the past five years: breakthrough technology alone does not create markets. Regulatory frameworks do. Europe’s food fermentation alliance is now building those frameworks — not from the top down, but from the inside out.

FermentTracker covers the precision fermentation industry weekly. Subscribe for data-driven analysis of the technologies reshaping food, materials, and chemicals.